Instituto Massone S.A.
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering biological active pharmaceutical ingredients, valid until 2028-04-22. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. Process number 25351143379202630.
- Type
- Manufacturer
- Location
- Argentina
- Categories
- 药品制造
- Markets
- 阿根廷, 巴西
Listed in a source registry
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- registered-manufacturer (green), checked 2026-08-21 Jordan Food and Drug Administration (JFDA), approved manufacturing sites (open data portal of Jordan)
- tax-filing-active (green), checked 2026-08-15 ARCA (Argentine tax authority), full taxpayer status file (Constancia de inscripcion, RG 1817)
- registry-id-verified (green), checked 2026-08-21 Taxpayer status file (Constancia de inscripcion)
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)